Home :: Medication :: Synagis

Latest Synagis News

MedImmune Reports 2005 Financial Results - PR Newswire (press release)

Worldwide Sales of Synagis increased 13 percent in 2005 over 2004. MedImmune reported 45-percent growth in Sales of Synagis to our international distributor, Abbott International, in 2005 as demand continued to increase in several key international markets. During 2005, the label for Synagis was expanded in Japan to include usage in children with congenital heart disease. Synagis has now been approved in 61 countries outside the United States. In the U.S., the first half of the calendar year was strong, while the 2005-2006 RSV season started slower than expected due primarily to changes in payer guidelines, the effects of Hurricanes Katrina and Rita on certain Sales territories, and an early disruption in the product's distribution network. In addition, Sales patterns in the quarter were affected by conversion of the U.S. supply from the lyophilized formulation to the new liquid formulation of Synagis, which primarily occurred during the month of November.

Synagis

No Ebay Marketplace Listings Found